Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CORCEPT THERAPEUTICS INC Director's Dealing 2011

May 31, 2011

30681_dirs_2011-05-31_1a1e0013-a0c9-4d9d-9ad8-76dc89d07634.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2011-05-27

Reporting Person: ROE ROBERT L (President and Secretary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-05-27 Common stock M 50000 $1.50 Acquired 82007 Direct
2011-05-27 Common stock S 50000 $4.7507 Disposed 32007 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-05-27 Stock option $1.50 M 50000 Disposed 2017-04-16 Common stock (50000) Direct

Footnotes

F1: The sale is made pursuant to terms of a 10b5-1 plan in effect at the time of sale of the shares.

F2: Fully exerciseable.